Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.20011 | 90 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.46961 | 91 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.63069 | 92 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.72187 | 92 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.93572 | 93 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.72997 | 89 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.36024 | 86 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.78845 | 88 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.85297 | 88 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.60137 | 92 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.81688 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.44833 | 91 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.54916 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.58537 | 92 |